Bcl-7c Activators

Venetoclax, Navitoclax, and ABT-737 are direct inhibitors of Bcl-2 family proteins, which are key regulators of apoptosis. Their ability to modulate these proteins could indirectly affect Bcl-7c, potentially influencing its role in apoptotic signaling.

These compounds also target Bcl-2 family proteins but with different specificities and mechanisms. Their actions on these proteins could indirectly influence Bcl-7c's function, particularly in the context of cell survival and apoptosis. Compounds like Chelerythrine and Sanguinarine, which induce apoptosis through different mechanisms, might also impact Bcl-7c's activity. Additionally, inhibitors like BM-1197, WEHI-539, and Sabutoclax, which have varying specificities within the Bcl-2 family, suggest potential indirect pathways through which Bcl-7c's functional activity might be modulated.